130 related articles for article (PubMed ID: 36451443)
1. The correlation of serum sirt6 with clinical outcome and prognosis in patients with gastric cancer.
Li D; Cao C
Medicine (Baltimore); 2022 Nov; 101(47):e31568. PubMed ID: 36451443
[TBL] [Abstract][Full Text] [Related]
2. A comprehensive evaluation of serum tRF-29-R9J8909NF5JP as a novel diagnostic and prognostic biomarker for gastric cancer.
Li X; Zhang Y; Li Y; Gu X; Ju S
Mol Carcinog; 2023 Oct; 62(10):1504-1517. PubMed ID: 37314123
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of serum miR-25 as a diagnostic and prognostic biomarker in human gastric cancer.
Kong Y; Ning L; Qiu F; Yu Q; Cao B
Cancer Biomark; 2019; 24(4):477-483. PubMed ID: 30909187
[TBL] [Abstract][Full Text] [Related]
4. The value of serum RASSF10 hypermethylation as a diagnostic and prognostic tool for gastric cancer.
Xue WJ; Feng Y; Wang F; Li P; Liu YF; Guo YB; Wang ZW; Mao QS
Tumour Biol; 2016 Aug; 37(8):11249-57. PubMed ID: 26945573
[TBL] [Abstract][Full Text] [Related]
5. Circulating SHIP2 mRNA as a novel biomarker in the diagnosis and prognosis of gastric cancer.
Xie JF; Xie NS; Tang JH; Gu QP; Luo QT
Eur Rev Med Pharmacol Sci; 2017 Nov; 21(22):5129-5134. PubMed ID: 29228424
[TBL] [Abstract][Full Text] [Related]
6. Serum Small Proline-Rich Protein 2A (SPRR2A) Is a Noninvasive Biomarker in Gastric Cancer.
Xu X; Wei S; Chen Y; Yu D; Wang X; Dong X
Dis Markers; 2020; 2020():8493796. PubMed ID: 32908616
[TBL] [Abstract][Full Text] [Related]
7. Serum OPN expression for identification of gastric cancer and atrophic gastritis and its influencing factors.
Chen T; Sun L; He C; Gong Y; Xu Q; Yuan Y
PLoS One; 2014; 9(12):e114005. PubMed ID: 25479069
[TBL] [Abstract][Full Text] [Related]
8. The Association of HOTAIR with the Diagnosis and Prognosis of Gastric Cancer and Its Effect on the Proliferation of Gastric Cancer Cells.
Xu Z; Chen H; Yang B; Liu X; Zhou X; Kong H
Can J Gastroenterol Hepatol; 2019; 2019():3076345. PubMed ID: 31281803
[TBL] [Abstract][Full Text] [Related]
9. Circulating circRNA Has_Circ_0141633 Serves as a Potential Biomarker for Gastric Cancer.
Yin G; Zheng S; Shan Y; Zhang J; Ying R; Kong W
Clin Lab; 2020 Sep; 66(9):. PubMed ID: 32902223
[TBL] [Abstract][Full Text] [Related]
10. H19 serves as a diagnostic biomarker and up-regulation of H19 expression contributes to poor prognosis in patients with gastric cancer.
Chen JS; Wang YF; Zhang XQ; Lv JM; Li Y; Liu XX; Xu TP
Neoplasma; 2016; 63(2):223-30. PubMed ID: 26774144
[TBL] [Abstract][Full Text] [Related]
11. Methylation status of TRAF2 is associated with the diagnosis and prognosis of gastric cancer.
Zhang J; Dai WJ; Yang XZ
Int J Clin Exp Pathol; 2015; 8(11):14228-34. PubMed ID: 26823737
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic and Prognostic Value of Serum MicroRNA-206 in Patients with Gastric Cancer.
Hou CG; Luo XY; Li G
Cell Physiol Biochem; 2016; 39(4):1512-20. PubMed ID: 27614739
[TBL] [Abstract][Full Text] [Related]
13. MiR-1236-3p serves as a new diagnostic and prognostic biomarker for gastric cancer.
An JX; Ma ZS; Ma MH; Shao S; Cao FL; Dai DQ
Cancer Biomark; 2019; 25(2):127-132. PubMed ID: 31045511
[TBL] [Abstract][Full Text] [Related]
14. Serum fibrinogen levels are positively correlated with advanced tumor stage and poor survival in patients with gastric cancer undergoing gastrectomy: a large cohort retrospective study.
Yu X; Hu F; Yao Q; Li C; Zhang H; Xue Y
BMC Cancer; 2016 Jul; 16():480. PubMed ID: 27418164
[TBL] [Abstract][Full Text] [Related]
15. [Studies on the cut-off value of serum pepsinogen abnormality for screening chronic atrophic gastritis and gastric carcinoma].
Li YH; Zhang XH; Huang B; Wang JL; Mi JM; Shen HT; Zhang ZG; Yan X; Xing LX; Wang SJ
Zhonghua Liu Xing Bing Xue Za Zhi; 2006 Oct; 27(10):840-4. PubMed ID: 17343174
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of H. pylori Infection and Atrophic Gastritis in a Population-based Screening with Serum Biomarker Panel (GastroPanel®) in St. Petersburg.
Roman LD; Lukyanchuk R; Sablin OA; Araslanova EI; Eklund C; Hendolin P; Paloheimo L; Syrjänen K
Anticancer Res; 2016 Aug; 36(8):4129-38. PubMed ID: 27466521
[TBL] [Abstract][Full Text] [Related]
17. Atrophic gastritis and gastric cancer tissue miRNome analysis reveals hsa-miR-129-1 and hsa-miR-196a as potential early diagnostic biomarkers.
Varkalaite G; Vaitkeviciute E; Inciuraite R; Salteniene V; Juzenas S; Petkevicius V; Gudaityte R; Mickevicius A; Link A; Kupcinskas L; Leja M; Kupcinskas J; Skieceviciene J
World J Gastroenterol; 2022 Feb; 28(6):653-663. PubMed ID: 35317427
[TBL] [Abstract][Full Text] [Related]
18. Circulating miR-222 in plasma and its potential diagnostic and prognostic value in gastric cancer.
Fu Z; Qian F; Yang X; Jiang H; Chen Y; Liu S
Med Oncol; 2014 Sep; 31(9):164. PubMed ID: 25129310
[TBL] [Abstract][Full Text] [Related]
19. The significance of preoperative serum carcinoembryonic antigen levels in the prediction of lymph node metastasis and prognosis in locally advanced gastric cancer: a retrospective analysis.
Wang K; Jiang X; Ren Y; Ma Z; Cheng X; Li F; Xiao J; Yu Z; Jiao Z
BMC Gastroenterol; 2020 Apr; 20(1):100. PubMed ID: 32276616
[TBL] [Abstract][Full Text] [Related]
20. SIRT6 inhibits growth of gastric cancer by inhibiting JAK2/STAT3 pathway.
Zhou J; Wu A; Yu X; Zhu J; Dai H
Oncol Rep; 2017 Aug; 38(2):1059-1066. PubMed ID: 28656307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
